on INNATE PHARMA (EPA:IPH)
Innate Pharma announces its participation in upcoming investor conferences
Innate Pharma SA, a publicly traded biopharmaceutical company, announced that several of its executives will participate in investor conferences in June 2024. Hervé Brailly, Sonia Quaratino, Yannis Morel and Arvind Sood will represent the company at these international events.
The conference schedule includes the Jefferies Global Healthcare Conference in New York June 5-6, and the Goldman Sachs 45th Annual Global Healthcare Conference in Miami June 10-13. Virtual participation is planned for the HC Wainwright 2nd Annual Immune Cell Engager Conference on June 25. Finally, the team will be present at the Stifel 2nd European Healthcare Summit in Lyon from June 25 to 27.
These conferences are strategic opportunities for Innate Pharma to present its innovations in immunotherapy and to strengthen relationships with investors and industrial partners.
R. E.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all INNATE PHARMA news